Elisha Yanay - Net Worth and Insider Trading

Elisha Yanay Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Elisha Yanay owns 1 companies in total, including Raphael Pharmaceutical Inc (RAPH) .

Click here to see the complete history of Elisha Yanay’s form 4 insider trades.

Insider Ownership Summary of Elisha Yanay

Ticker Comapny Transaction Date Type of Owner
RAPH Raphael Pharmaceutical Inc 2010-09-30 director

Elisha Yanay Trading Performance

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Elisha Yanay Ownership Network

Ownership Network List of Elisha Yanay

No Data

Ownership Network Relation of Elisha Yanay

Insider Network Chart

Elisha Yanay Owned Company Details

What does Raphael Pharmaceutical Inc do?

Who are the key executives at Raphael Pharmaceutical Inc?

Elisha Yanay is the director of Raphael Pharmaceutical Inc. Other key executives at Raphael Pharmaceutical Inc include director & 10 percent owner & Chief Executive Officer Shlomo Pilo , director & Chief Technology Officer Hayon Igal Louria , and director & 10 percent owner & President Guy Ofir .

Raphael Pharmaceutical Inc (RAPH) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Raphael Pharmaceutical Inc (RAPH) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Raphael Pharmaceutical Inc (RAPH) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Raphael Pharmaceutical Inc (RAPH)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Raphael Pharmaceutical Inc Insider Transactions

No Available Data

Elisha Yanay Mailing Address

Above is the net worth, insider trading, and ownership report for Elisha Yanay. You might contact Elisha Yanay via mailing address: C/o Advanced Technology Acquisition Corp, 14 A Achimeir Street, Ramat Gan L3 52587.

Discussions on Elisha Yanay

No discussions yet.